Veradermics, Incorporated (MANE) Stock Statistics & Valuation Metrics

Veradermics, Incorporated has a market cap or net worth of $3.92B. The enterprise value is $3.67B.

Veradermics, Incorporated has 41,778,687 shares outstanding. The number of shares has decreased by -2.65% in one year.

Veradermics, Incorporated’s return on equity (ROE) is 0.58 and return on invested capital (ROIC) is -50.43%.

The current PE Ratio of Veradermics, Incorporated is ―. Veradermics, Incorporated’s PEG ratio is -0.01.

In the last 12 months, Veradermics, Incorporated had revenue of 0.00 and earned -70.00M in profits. Earnings per share was -2.38.

In the last 12 months, operating cash flow was -44.80M and capital expenditures -5.00K, giving a free cash flow of -44.80M billion.

Veradermics, Incorporated pays an annual dividend of ―, resulting in a dividend yield of ―

Veradermics, Incorporated upcoming earnings date is May 12, 2026, Before Open (Confirmed).

Veradermics, Incorporated as a current ratio of 16.66, with Debt / Equity ratio of 0.00%

In the past 12 months, Veradermics, Incorporated has paid 0.00 in taxes.

Veradermics, Incorporated EV to EBITDA ratio is -18.61, with an EV/FCF ratio of -18.18.

Veradermics, Incorporated has $390.80M in cash and marketable securities with $0.00 in debt, giving a net cash position of $390.80M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Veradermics, Incorporated is $136.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy